Max India Limited (MAXIND) | Stock Overview & Key Data
Max India Limited Performance Comparison
Stock Range
Today's Range
Low: ₹215.65
High: ₹220.84
on October 3, 2025
52 Week Range
Low: ₹169.00
High: ₹320.69
on March 17, 2025
on December 12, 2024
All-Time High: ₹338.00 on July 8, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR11.9B
EPS
-30.09
P/E Ratio (TTM)
-7.13
Forward P/E
N/A
P/B Ratio
2.63
PEG Ratio
0.91
Div. Yield
N/A
ROE
-39.14%
Beta
0.166
Debt to Equity
28.52
Financial Highlights
Profitability
Gross Margin
76.14%
Operating Margin
-59.65%
Profit Margin
-80.20%
Returns and Earnings
Return on Assets (TTM)
-22.18%
Return on Equity (TTM)
-39.14%
EBITDA
INR-784.7M
Net Income (TTM)
INR-1.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR37.57
Quarterly Revenue Growth (YoY)
28.70%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Max India Limited MAXIND | 11.92B Small-cap | 1.48% | -0.49% | 15.83% | 15.90% | -21.22% | -11.05% | 157.53% | 277.19% |
| Max Healthcare MAXHEALTH | 1.05T Large-cap | -4.82% | -7.99% | -17.84% | -4.65% | -6.18% | 15.42% | 157.02% | 865.85% |
| Apollo Hospitals APOLLOHOSP | 1.08T Large-cap | -0.81% | -3.70% | -1.53% | 11.66% | 1.08% | 9.98% | 69.53% | 227.15% |
| Indraprastha Medical INDRAMEDCO | 42.43B Small-cap | 3.48% | -3.24% | -7.50% | 14.75% | -14.65% | 9.20% | 642.22% | 819.28% |
| Shalby SHALBY | 28.58B Small-cap | 7.74% | 35.22% | 42.91% | 25.35% | 15.19% | -1.79% | 99.07% | 178.07% |
| Dr. Agarwal's Eye DRAGARWQ | 23.46B Small-cap | 2.98% | 9.84% | 14.47% | 16.54% | -23.53% | 4.92% | 358.10% | 1,895.43% |
Ownership & Short Interest
Insider Ownership
60.03%
Institutional Ownership
0.07%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
597K
Average 90-Day Volume
228K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MAXIND's 52-week high and low?
- In the last 52 weeks, Max India Limited reached a high of ₹320.69 (on December 12, 2024) and a low of ₹169.00 (on March 17, 2025).
- What is the market cap and P/E ratio for MAXIND?
- Curious about Max India Limited's size and valuation? Its market capitalization stands at 11.92B. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.13, and the forward P/E (looking ahead) is N/A.
- Does MAXIND pay dividends? If so, what's the yield?
- As for dividends, Max India Limited isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Max India Limited's main competitors or similar companies to consider before investing?
When looking at Max India Limited, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.05T Healthcare Medical Care Facilities 15.42% 157.02% Apollo Hospitals
APOLLOHOSP1.08T Healthcare Medical Care Facilities 9.98% 69.53% Indraprastha Medical
INDRAMEDCO42.43B Healthcare Medical Care Facilities 9.20% 642.22% Shalby
SHALBY28.58B Healthcare Medical Care Facilities -1.79% 99.07% Dr. Agarwal's Eye
DRAGARWQ23.46B Healthcare Medical Care Facilities 4.92% 358.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Max India Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Max India Limited's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -39.14%, the Debt to Equity ratio from the most recent quarter is 28.52, and its Gross Profit Margin stands at 76.14%.
- What is the recent revenue and earnings growth for MAXIND?
- Looking at Max India Limited's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 28.70%, and quarterly earnings saw a YoY growth of N/A.
- How much of MAXIND stock is held by insiders and institutions?
- Wondering who owns Max India Limited stock? Company insiders (like executives and directors) hold about 60.03% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.07%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.